News: Anand Nambiar appointed as MD at Merck

C-Suite

Anand Nambiar appointed as MD at Merck

The drug company, Merck, appointed Anand Nambiar as its new MD in place of Dr. Claus-Dieter Boedecker who resigned from the company. Boedecker submitted his resignation to the Board of the company owing his desire to relocate to his home country, Germany. Nambiar will take over as the new MD from January 31, 2015.

The drug company, Merck, appointed Anand Nambiar as its new MD in place of Dr. Claus-Dieter Boedecker who resigned from the company. Boedecker submitted his resignation to the Board of the company owing his desire to relocate to his home country, Germany. Nambiar will take over as the new MD from January 31, 2015.

Read the Economic Times news report here.

Read full story

Topics: C-Suite, #Appointments, #Corporate

Did you find this story helpful?

Author


QUICK POLL

Post-COVID, which aspect of work will technology impact the most?

2 months free subscription
q_auto,f_auto/v1599122279/mag-september-2020.png

Subscribe to all new People Matters HR Magazine

.

Subscribe
And Save 59% plus Two months free

Subscribe now

Are we too remote for our employees?

Participate and get your free pulse report.

Participate Now